TNON

Insider Trades

Name	Value	Action	Price	Current Price
Foster Steven MDirector, Officer: CEO And President Disclosure amount unavailable19.5k shares BuyNov 14, 2025 -- --
Geist Wyatt D.Chief Innovation Officer Disclosure amount unavailable19.5k shares BuyNov 14, 2025 -- --
Grawey Nathaniel A.Chief Commercial Officer Disclosure amount unavailable101.2k shares BuyNov 14, 2025 -- --
Grawey Nathaniel A.Chief Commercial Officer $117k101.2k shares BuyNov 14, 2025 $1.16 --
Foster Steven MDirector, Officer: CEO And President $23k19.5k shares BuyNov 14, 2025 $1.16 --
Geist Wyatt D.Chief Innovation Officer $23k19.5k shares BuyNov 14, 2025 $1.16 --

News

accessnewswire.comTenon(R) Medical Reports First Quarter 2026 Financial Resultsaccessnewswire.comMay 12

accessnewswire.comTenon Medical, Inc. Sets Date for First Quarter 2026 Earningsaccessnewswire.comMay 1

seekingalpha.comTenon Medical, Inc. (TNON) Q4 2025 Earnings Call Transcriptseekingalpha.comMar 19

accessnewswire.comTenon(R) Medical Reports Fourth Quarter and Full Year 2025 Financial Resultsaccessnewswire.comMar 19

Trade TNON

About Tenon Medical, Inc.

Tenon Medical, Inc. is a medical device firm dedicated to developing advanced surgical implant solutions. These systems are designed to enhance sacroiliac joint (SIJ) fixation and fusion operations, ultimately leading to better patient outcomes. The company markets The CATAMARAN SIJ Fusion System, which includes both specialized instruments and implants, specifically engineered for the preparation and secure fusion of the SI-Joint. This product is distributed throughout the United States and Puerto Rico. Founded in 2012, Tenon Medical's operations are headquartered in Los Gatos, California.

CEO: Steven Foster
IPO Date: Apr 27, 2022

Market Data

Volume: 77.7K

Valuation

Market Cap: $4.4M

Financials

Financial statement snapshot is not available yet.

Events

EarningsAug 12

EPS est. -0.24